Fan Linlin, Wu Caiyun, Lu Changxia
College of Nursing, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Endocrine Nephrology Department, Gansu Baoshihua Hospital, Lanzhou, Gansu, China.
Medicine (Baltimore). 2025 Jan 10;104(2):e41025. doi: 10.1097/MD.0000000000041025.
This retrospective study aims to assess the adjunctive efficacy of warm needle moxibustion and gua sha care in the treatment of eszopiclone tablets on sleep quality and psychological stress in insomnia patients. Data of 138 insomnia patients from Gansu Baoshihua hospital between January and December 2022 were collected. Patients were bifurcated into 2 groups: those solely treated with eszopiclone (n = 71) and those administered a combined regimen of eszopiclone, warm needle moxibustion, and gua sha (n = 67). Sleep quality, psychological stress, and daytime drowsiness were assessed using the Pittsburgh Sleep Quality Index (PSQI), Perceived Stress Scale-10 (PSS-10), and Epworth Sleepiness Scale (ESS), respectively. Adverse effects were also monitored. Baseline demographics and clinical characteristics were comparable between the 2 groups. Post-intervention, the intervention group exhibited significant reductions in PSQI and ESS scores (P < .05), whereas the control group showed no significant changes. The PSS-10 scores remained unchanged in both groups post-intervention. The intervention group reported a significant decrease in the prevalence of nausea and dizziness posttreatment (P < .05), with a notably lower post-intervention nausea prevalence compared to the control group (P < .05). Incorporating warm needle moxibustion and gua sha nursing care into the eszopiclone treatment regimen potentially amplify sleep quality while reducing side effects in patients with insomnia.
本回顾性研究旨在评估温针艾灸和刮痧护理辅助治疗艾司佐匹克隆片对失眠患者睡眠质量和心理压力的影响。收集了2022年1月至12月甘肃省宝世华医院138例失眠患者的数据。患者被分为两组:单纯接受艾司佐匹克隆治疗的患者(n = 71)和接受艾司佐匹克隆、温针艾灸和刮痧联合治疗的患者(n = 67)。分别使用匹兹堡睡眠质量指数(PSQI)、感知压力量表-10(PSS-10)和爱泼沃斯思睡量表(ESS)评估睡眠质量、心理压力和日间嗜睡情况。同时监测不良反应。两组患者的基线人口统计学和临床特征具有可比性。干预后,干预组的PSQI和ESS评分显著降低(P < 0.05),而对照组无显著变化。两组干预后的PSS-10评分均未改变。干预组治疗后恶心和头晕的发生率显著降低(P < 0.05),干预后恶心发生率明显低于对照组(P < 0.05)。将温针艾灸和刮痧护理纳入艾司佐匹克隆治疗方案可能会提高失眠患者的睡眠质量,同时减少副作用。